Managed Healthcare Executive September 6, 2024
Patrick Cooney, president of The Federal Group, a Washington, D.C., lobbying firm says prospects for legislation passing this year, albeit during the post-election lameduck session, are good partly because the PBM legislation would produce Medicare savings that could be put toward other uses.
Congress has been considering legislation that would increase transparency into pharmacy benefit management (PBM) contracts and ban certain PBM practices, such as spread pricing.
Patrick Cooney, president of The Federal Group, a Washington, D.C., lobbying firm, said in an interview conducted at the 2024 PBMI Annual National Conference that it is “highly likely that PBM legislation will get across the finish line,” partly because provisions of the current bills will save Medicare money.
Cooney said that the...
Today's Sponsors
Today's Sponsor